Palbociclib 125mgCapsule
Anti-Cancer

Palbociclib 125mg

Palbociclib

Palnat (Palbociclib 125mg) is an anti-cancer medicine that works by blocking proteins (CDK4/6) that control cancer cell growth, slowing tumor progression in hormone receptor-positive breast cancer. It is used in combination with an aromatase inhibitor or fulvestrant for HR-positive, HER2-negative advanced breast cancer. Available in 75mg, 100mg, and 125mg capsules for global pharmaceutical export.

Strengths

75mg / 100mg / 125mg

Packing

21 capsules/pack

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Palbociclib 75mg / 100mg / 125mg
Dosage Form
Capsule
Available Strengths
75mg / 100mg / 125mg
Packing
21 capsules/pack
Route of Administration
Oral, with food
Dosage
125mg once daily for 21 consecutive days followed by 7 days off; 28-day cycle
Indications
HR-positive, HER2-negative advanced or metastatic breast cancer in combination with aromatase inhibitor or fulvestrant
Country of Origin
India (WHO-GMP Certified)
Storage
Store at 20-25°C
Shelf Life
36 months
Side Effects
Neutropenia, leukopenia, fatigue, anemia, upper respiratory infection, nausea, stomatitis, alopecia
Precautions
Monitor CBC before and during treatment; dose reduction for neutropenia; avoid grapefruit; avoid strong CYP3A inhibitors

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Need bulk pricing for Palbociclib 125mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote